We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

49 hedge funds and large institutions have $9.99M invested in Perspective Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.12% more ownership

Funds ownership: 1.18% → 1.3% (+0.12%)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

2% less funds holding

Funds holding: 50 → 49 (-1)

17% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 12

55% less capital invested

Capital invested by funds: $22M → $9.99M (-$12M)

Holders
49
Holders Change
-1
Holders Change %
-2%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
10
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$2.48M
2
Jane Street
Jane Street
New York
+$62.8K
3
HF
HRT Financial
New York
+$47.9K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$46.3K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$31.2K

Top Sellers

Rank Fund Capital Flow
1
PIC
Portland Investment Counsel
Ontario, Canada
-$683K
2
BlackRock
BlackRock
New York
-$373K
3
Citadel Advisors
Citadel Advisors
Florida
-$111K
4
Renaissance Technologies
Renaissance Technologies
New York
-$32.3K
5
Cerity Partners
Cerity Partners
New York
-$26.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.51M +$46.3K +9,919 +0.8%
BBA
2
Baker Bros. Advisors
New York
$2.09M +$2.48M +532,041 +229%
BlackRock
3
BlackRock
New York
$1.24M -$373K -79,939 -15%
PCM
4
Perkins Capital Management
Minnesota
$731K -$1.4K -300 -0.1%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$689K +$31.2K +6,675 +3%
OCM
6
Osterweis Capital Management
California
$433K – – –
HighTower Advisors
7
HighTower Advisors
Illinois
$314K – – –
State Street
8
State Street
Massachusetts
$184K +$9.85K +2,110 +3%
TMWM
9
Taylor & Morgan Wealth Management
Michigan
$157K -$9.6K -2,058 -3%
Northern Trust
10
Northern Trust
Illinois
$108K -$784 -168 -0.4%
Renaissance Technologies
11
Renaissance Technologies
New York
$101K -$32.3K -6,928 -16%
BCM
12
Bridgeway Capital Management
Texas
$50.4K – – –
Bank of New York Mellon
13
Bank of New York Mellon
New York
$42.2K – – –
Jane Street
14
Jane Street
New York
$40.2K +$62.8K +13,458 +1,101%
Creative Planning
15
Creative Planning
Kansas
$35.4K -$2.33K -500 -4%
Charles Schwab
16
Charles Schwab
California
$31.8K – – –
WE
17
Wealth Effects
Massachusetts
$30.1K – – –
HF
18
HRT Financial
New York
$28K +$47.9K +10,271 New
TSS
19
Two Sigma Securities
New York
$21K -$11.3K -2,420 -24%
Cetera Investment Advisers
20
Cetera Investment Advisers
Illinois
$17.8K – – –
Morgan Stanley
21
Morgan Stanley
New York
$15.6K -$2.42K -518 -8%
Commonwealth Equity Services
22
Commonwealth Equity Services
Massachusetts
$12K – – –
Thrivent Financial for Lutherans
23
Thrivent Financial for Lutherans
Minnesota
$11K – – –
JFG
24
JDM Financial Group
Texas
$9.58K – – –
Wells Fargo
25
Wells Fargo
California
$9.47K +$163 +35 +1%
1
2 3

CATX Hedge Fund Activity: Q3 2023 in Review

49 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q3 2023, worth a combined $9.99M — down 55% from $22M a quarter earlier.

Fund positioning in CATX was balanced in Q3 2023: 4 funds opened new positions, 4 closed out, 10 added to existing stakes and 12 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $2.48M. The largest seller was Portland Investment Counsel, exiting entirely with an estimated $683K sold.

  • 49 institutional investors held Perspective Therapeutics (CATX) as of Q3 2023, down from 50 in Q2 2023.
  • Funds reported $9.99M of Perspective Therapeutics stock for Q3 2023, down 55% quarter-over-quarter.
  • 4 funds opened new Perspective Therapeutics positions in Q3 2023 and 4 closed out, a net change of 0 holders.
  • The largest Perspective Therapeutics buyer in Q3 2023 was Baker Bros. Advisors, an estimated $2.48M added.
  • The largest Perspective Therapeutics seller in Q3 2023 was Portland Investment Counsel, an estimated $683K sold.

Based on aggregated 13F filings for Q3 2023.